StonvexLoading…
StonvexStonvexStonvexCore line items from SNA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 2026-04-04 | Annual 2026 2026-01-03 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $1.20B | $4.71B | $3.49B | $2.30B |
Operating Income | $318.80M | $1.33B | $988.10M | $640.70M |
Net Income | $247.00M | $1.02B | $756.20M | $490.80M |
EPS (Diluted) | $4.69 | $19.19 | $14.24 | $9.24 |
Total Assets | $8.52B | $8.41B | $8.36B | $8.20B |
Total Liabilities | $2.53B | $2.46B | $2.51B | $2.46B |
Cash & Equivalents | $1.75B | $1.62B | $1.53B | $1.46B |
Free Cash Flow OCF − CapEx | $347.50M | $1.01B | $751.10M | $493.10M |
Shares Outstanding | 52.70M | 53.00M | 53.06M | 53.15M |